These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 166833)

  • 1. Antiandrogenic effect of spirolactones: mechanism of action.
    Corvol P; Michaud A; Menard J; Freifeld M; Mahoudeau J
    Endocrinology; 1975 Jul; 97(1):52-8. PubMed ID: 166833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiandrogenic effect of spirolactones: different mechanisms of action (author's transl)].
    Mahoudeau JA; Corvol P; Valcke JC; Menard J; Bricaire H
    Ann Endocrinol (Paris); 1976; 37(1):57-8. PubMed ID: 1015793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of spironolactone and digitalis with the 5 alpha-dihydrotestosterone (DHT) receptor of rat ventral prostate.
    Pita JC; Lippman ME; Thompson EB; Loriaux DL
    Endocrinology; 1975 Dec; 97(6):1521-7. PubMed ID: 173527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
    Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action].
    Corvol P; Mahoudeau JA; Valcke JC; Ménard J; Bricaire H
    Nouv Presse Med; 1976 Mar; 5(11):691-4. PubMed ID: 177946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
    Liang T; Heiss CE
    J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of a new antialdosterone compound, prorenone.
    Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
    Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of spironolactone anti-androgenic action: inhibition of androstanolone binding to rat prostate androgen receptor.
    Bonne C; Raynaud JP
    Mol Cell Endocrinol; 1974 Dec; 2(1):59-67. PubMed ID: 4376096
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate effect in dogs with the aldosterone receptor blocker eplerenone.
    Levin S; McMahon E; John-Baptiste A; Bell RR
    Toxicol Pathol; 2013 Feb; 41(2):271-9. PubMed ID: 23242577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
    Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors.
    Ulmann A; Menard J; Corvol P
    Endocrinology; 1975 Jul; 97(1):46-51. PubMed ID: 166832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a specific dihydrotestosterone-binding cytosol receptor in the human prostate.
    Geller J; Cantor T; Albert J
    J Clin Endocrinol Metab; 1975 Nov; 41(5):854-62. PubMed ID: 52654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver.
    Francavilla A; Di Leo A; Eagon PK; Polimeno L; Guglielmi F; Fanizza G; Barone M; Starzl TE
    Gastroenterology; 1987 Oct; 93(4):681-6. PubMed ID: 3623016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirolactones: clinical and pharmacologic studies.
    Corvol P; Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Menard J
    Adv Nephrol Necker Hosp; 1977; 7():199-215. PubMed ID: 208407
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors.
    Eil C; Edelson SK
    J Clin Endocrinol Metab; 1984 Jul; 59(1):51-5. PubMed ID: 6725525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the androgen receptor in the anterior pituitary of the rat.
    Naess O; Hansson V; Djoeseland O; Attramadal A
    Endocrinology; 1975 Dec; 97(6):1355-63. PubMed ID: 173521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pesticides on 3H-dihydrotestosterone binding to cytosol proteins from various tissues of the mouse.
    Schein LG; Donovan MP; Thomas JA; Felice PR
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):461-70. PubMed ID: 232714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An approach to the anabolic action of androgens by an experimental system.
    Michel G; Baulieu EE
    Environ Qual Saf Suppl; 1976; (5):54-9. PubMed ID: 182485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of androgens in 5 alpha-reductase-deficient human genital skin fibroblasts: inhibition by progesterone and its metabolites.
    Hodgins MB
    J Endocrinol; 1982 Sep; 94(3):415-27. PubMed ID: 7119651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.